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Using in situ hybridization techniques and RNase protection 
assays, type II collagen mRN A was transiently detected in the 
epidermis of chick embryonic skins during days 9-15 after 
fertilization, with a maximum expression at day 11. Immun-
ohistochemical studies demonstrated that deposition of type 
II collagen was also transiently localized at the subepidermal 
region during days 10-15. Type II collagen gene and gene 
product concomitantly started to decline preferentially at the 
region where feather buds were being formed on day 12, and 
T ype II collagen is the major and unique collagenous component of cartilage and plays a critical role in chondrogenesis during embryonic development [1]. However, it has been demonstrated that type II colla-gen is much more widely distributed during early de-
velopment than previously thought. The presence of a small 
amount of type II collagen or its biosynthesis has been detected in 
nonchondrogenic tissues including embryonic notochord [2,3], 
corneal epithelium [4] , and neural retina [5]. Furthermore, type II 
collagen has been demonstrated to be present at the ectodermal-me-
senchymal interfaces throughout the trunk of the chick embryo at 
the very early stages (day 2-3) and subsequently disappears with 
development [6,7] . Recently type II collagen has been demonstrated 
to be present in the subepidermal matrix of proximal hindlimb on 
day 7-1-2 and was absent at the root of the feather buds on day 10 
[8,9]. 
In the course of the studies on the developmental regulation of 
collagen gene expression using chick embryonic skin [10], we found 
the expression of type II collagen in chick embryonic skin, which 
led us to investigate its expression quantitatively and extend the 
investigation to human fetal skin. 
MATERIALS AND METHODS 
Skins Eggs of white leghorn chickens were obtained on day 5 after fertil-
ization from Nippon Biomaterial Inc. and incubated in a humid atmosphere 
at 38 ' C. Embryos were staged according to the days after fertilization. The 
skins of the face or back were resected with scissors and divided into two 
parts. An aliquot for immunohistochemical and in silt< hybridization studies 
was fixed immediately in 4% paraformaldehyde in 0.1 M phosphate buffer 
(pH 7.4) for 3 h at 4 ' C, and washed with 0.1 M phosphate buffer. The 
specimens were dehydrated by graded alcohol series and embedded in paraf-
fin at 62' C, and subsequently sectioned serially at 3-.um thickness. The 
remaining parts were stored immediately at -80 ' C for RNA extraction. 
Specimens of human fetuses were obtained from spontaneous or legal 
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thereafter diminished at the region between feather buds. 
Using immunohistochemical methods, type II collagen was 
also detected in human fetal scalp skin at 17 - 23 fetal weeks 
at the subepidermal region, excluding the region beneath the 
hair follicles. These results indicate that the lack of type II 
collagen expression is related to the development of feather 
and hair at a certain stage of chick embryonic and human fetal 
skin development. Key words: Type II collagen/skin/develop-
ment.] Invest Dermato1102:958-962, 1994 
abortion. Skins were resected from the scalp at the stages of 17,21, and 23 
weeks' gestation, from the back at the stage of 17 weeks' gestation, and fro.m 
the scalp of a 23-year-old normal adult, and were prepared for immunohis-
tochemical studies as described above. 
In Situ Hybridization T emplates for synthesis of RNA probes were con-
structed by subcloning the fragments of chicken type II procollagen cDNA 
(pYN2142, BamHI/EcoRI fragment corresponding to carboxy termmal 
propeptide of prolXI (II)) [11) into pGEM vectors (Prom ega Biotechnology). 
The RNA probes were transcribed from both strands with T7 or SP6 RNA 
polymerase and [a-3SSJ UTP (800 Ci/mmol, Amersham) (specific activity, 
1 X 109 dpm/ ,ug) according to the published protocol (Promega). Follow-
ing synthesis of RNA, DNA templates were destroyed by RNase-free 
DNase (Boehringer-Mannheim) treatment at 37 ' C for 30 min. The RNA 
probes were subjected to limited alkaline hydrolysis to shorten the size to 
about 150 base pairs (bp) [12J. The pretreatment and hybridization were 
performed according to Ingram et al [13J and Noji et al [14J. Tissue sections 
from various stages of chick embryonic skins were collected on poly-L-
lysine -coated slides. Sections were deparaflinated in xylene, rehydrated, 
acetylated, and prehybridized in a solution containing 50% formamide, 10 
ruM dithiothreitol (DTT) and 2 X sodium citrate buffer (SSe) at 50'C for 
20 min. Twenty microliters of hybridization mixture (50% formamide, 4 
mg/ml bovine serum albumin [BSA). 4 mg/ml tRNA, 10% dextran sulfate, 
and 2 X SSC) was applied to each slide and hybridization was carried out in a 
humid chamber at 50 ' C for 15 h with a probe concentration of 1 X 106 
dpm/.ul. The slides were washed in 50% formamide, 2 X SSC, and 10 ruM 
DDT at 50'C for 20 min and treated with 20,Ltg/ml RNase A at 37'C for 30 
min, then washed with 0.1 X SSC and 10 ruM DDT for 20 min three times 
at 50'C with shaking. The slides were dehydrated and air-dried. For autora-
diography, the slides were immersed in Kodak NTB2 emulsion (diluted 1 : 1 
with water) , air-dried, and exposed in a dry , light-tight box at 4 'C for 7 d, 
followed by development in Kodak D 19 developer for 3 min and staining 
with hematoxylin-eosin. 
Ribonuclease Protection Assays Ribonuclease protection assays were 
used to quantitatively assess the changes in steady-state levels of specific 
mRNAs during the chick skin development. The fragment (BamHI/PsI I, 
0.3 kilobase pairs [kbJ corresponding to the central portion of C-propeptide 
sequences of prolX2 (I)) derived from chicken type I procollagen cDNA 
(pCG45) [15] and the fragment (BamHI/PstI , 0 .5 kb corresponding to C-
propeptide sequences adjacent to C-protease cleavage site of proal (II)) de-
rived from chicken type II procollagen (p YN2142) [11 J were subcloned into 
the pGEM vector (Promega). Antisense RNA probes were transcribed from 
template sequences with SP6 RNA polymerase and labeled with [a_32P] 
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Figure 1. Detection of type II collagen mRNA by ill situ hybridization. Skin specimens were taken from chick embryo on days 8 (A), 10 (B) , 15 (C), and 18 
(D), and hybridized with type II collagen antisense RNA probe. Bar, 20 11m. 
VTP (400 Ci/mmol, Amersham) according to a published protocol (Pro-
mega). Full-length transcripts were purified from acrylamide (6% acryla-
mide/8 M urea) gel. RNAs were isolated from developing chick skins be-
rween days 8 and 20 [16] and the solutions were adjusted at 1 Ilg/Ill and 
stored at -80·C. The probes were hybridized with sample RNAs at 42·C 
overnight in the solution containing SO% formamide, 40 mM 1,4 piperazin-
ediethanesulfonic acid (Pipes), pH 6.4, 400 mM sodium acetate, pH 6.4, and 
1 roM ethylenediamine tetraacetic acid (EDTA). The solution was digested 
with RNase A (5 units/ml) and RNase Tl (1000 units/ml) at 37·C for 30 
min. The protected RNA fragments were analyzed on sequencing gel (6% 
acrylamide/8 M urea) and exposed on X-ray films at -SO·C for 24-48 h. 
IUlI:J1unohistochemical Studies for Type n Collagen Type II colla-
gen vvas purified from. human coastal c~ti1age .by pepsin tn:atment and 
repeating salt precipitations [17]. The punty was Judged by sodIUm dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Monoclonal anti-
body (clone number 4Cl1) against type II collagen was prepared according 
to a standard method [18]. Human type I, II, III, IV, and V collagens (Chemi-
con) vvere subjected to 10 - 20% gradient SDS-PAGE and transferred elec-
trophoretically to a nitrocellulose membrane (Schleicher & Schuell). After 
blocking with 5% normal swine serum, the membrane was incubated with 
antibody (1: 1000) overnight at 4·C then with horseradish peroxidase-
labeled second antibody (1: 500) (Dako) for 30 min at 37·C, and immersed 
in 0.02% diaminobenzidine/50 mM Tris-HCl, pH 7.4, containing 0.03% 
H2 0 2 (DAB solution) [19]. 
The sections were deparaffinated and treated with 1 % H20 2 in methanol 
for 1 h to minimize the endogenous peroxidase activity, and rinsed with 
phosphate-buffered saline (PBS). The sections were treated with 0.01 unit/ 
m1 chondroitinase ABC (Seikagaku Kogyo) in PBS at 37·C for 20 min and 
rinsed in PBS. The slides were then covered with 5% BSA in PBS for 1 h. 
The excess BSA was removed by blotting and sections were covered with 
monoclonal antibody (1 : 1000 dilution) to human type II collagen at room 
temperature for 1 h. The sections were rinsed in PBS three times and covered 
with t~e second antibody, anti-mouse immunoglobulin (Ig)G (Dako) at a 
1 : 40 dilution at room temperature for 1 h and rinsed with PBS. Antigenic 
sites on the sections were demonstrated by reaction with a mixture of 0.05% 
3,3' diaminobenzidine tetrahydrochloride in 0.1 M Tris-HCI buffer, pH 
7.4, and 0.01 % H 20 2 • The sections were counterstained with hematoxylin, 
dehydrated in ethanol, cleared in xylene, and mounted in Permount. 
RESULTS 
Detection of Type II Collagen mRNA in Chick Embryonic 
Skin by In Situ Hybridization During the early stages, from 
days 5 to 8 of chick embryo, no type II collagen mRNA was seen in 
the skins (days 5-7, not shown; day 8 in Fig 1A). On day 10 a 
number of grains were observed exclusively in the epidermis (Fig. 
1B). The number of grains in the epidermis started to decrease in the 
sites where feather buds formed on day 15 (arrows in Fig 1 C). When 
the feather formation was completed on day 18, positive grains in 
the epidermis between feather buds were no longer detected on day 
18 (Fig lD). 
Quantitative Analysis of Types I and II Procollagen mRNA 
by RNase Protection Assay Preliminary experiments using 
RNA isolated from chick skin and sclera (the tissue rich in type II 
collagen) on day 10 demonstrated that a unique and RNase-pro-
tected fragment with 551 nucleotides was detected in both tissues, 
with more significant intensity in sclera than skin (Fig 2). To opti-
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Figure 2. Detection of type II procollagen mRNA by RNase protection 
assay. RNAs were extracted from skin (lan es, 1,2) and sclera (Iall es 3,4) of 
10-day-old chick embryo and were hybridized with 32P-labeled type II pro-
collagen antisense transcript. RNase protection assays were performed with 
(lane 1) or without (Iatle 2) RNase digestion in skin RNA and with RNase 
digestion (Ianc 3) or without target RNA (lane 4) in sclera RNA. Protected 
fragment (551 nt) was detected in both tissues. 
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Figure 3. Quantitative analysis of type I procollagen mRNA during chick 
embryonic skin development using RNase protection assay. Two micro-
grams of sample RNAs from days 9 (Iatlc 1), 11 (latle 2), 15 (latlC 3) , 18 (lane 
4), and 20 (lane 5) were hybridized with 32P-labeled type I procollagen 
antisense transcript (77 pg). Control experiment was carried out without 
sample RNA (lane 6) or without RNase digestion (latle 7). 
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Figure 4. Quantitative analysis of type II procollagen mRNA during chick 
embryonic skin development using RNase protection assay. Eight micro-
grams of sample RNAs from days 9 (latle 1),11 (latlc 2),13 (latle 3),15 (latle 
4), 18 (Iatle 5), and 20 (lane 6) were hybridized with 32P-labeled type II 
procollagen antisense transcript (45 pg). Control experiment was carried out 
without sample RNA (Iatle 7) or without RNase digestion (lan es 8,9) . 
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Fi~re 5. Immunoblot analysis of the specificity of anti-type II collagen 
antibody. Type I - V collagens were resolved on 10 - 20% gradient SDS-
PAGE under reducing condition (left) and blotted to nitrocellulose filter. 
The blot was stained with the monoclonal antibody for type II collagen 
(right). 
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Figure 6. Immunohistochemical studies on the localization of type II collagen in chick embryonic and human fetal skins. Skin specimens were taken from the 
face of chick embryo on days 10 (A,B), 12 (C) , and 15 (D) or from the scalp of human fetus at 21 (B) and 23 (F) weeks and were stained with anti-type II 
collagen antibody. C in A represents cartilage. Bar in A , 500 Jim; bars in B-F, 50 Jim. 
mize the amounts of probes and input sample RNA, pilot assays 
were carried out with a range of total cellular RNA from chick 
embryonic skin on day 12 using a constant amount of antisense 
probes (77 and 45 pg of types I and II procollagen antisense probes 
calculated from specific activities; 2.6 X 108 and 2.0 X 108 cpm/)lg, 
respectively), which demonstrated input sample RNAs less than 2.5 
and 40 )lg were well correlated with the amounts of types I and II 
procollagen antisense probes, respectively (data not shown). From 
this result, 2 )lg and 8 )lg of sample RNAs prepared from various 
stages of skins were used for subsequent assays with types I and II 
procollagen RNA probes. Considerable type I procollagen mRNA 
was already detected on day 9 and no significant change was ob-
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served with development (Fig. 3). Type II procollagen mRNA was 
detected on day 9 and reached maximum levels on day 11. It subse-
quently showed a gradual reduction and was hardly detectable on 
days 15, 18, and 20 (Fig 4). The minor band just below 396 nt wil l 
be derived from unprotected probe with incomplete RNase digest. 
Distribution of Type II Collagen in Chick Embryonic and 
Human Fetal Skins Monoclonal antibody for type II collagen 
was found by immunoblot analysis to recognize only type II colla-
gen (Fig 5). Control experiment devoid of second antibody did not 
show any positive staining in chick embryonic and human fetal 
skins (not shown). 
Type II collagen first appeared as a weak line of staining in the 
interfaces between undifferentiated epidermal cells and mesen-
chyme on day 10 (arrows in Fig 6A,B) as well as in the cartilage (the 
tissue rich in type II collagen) (C in Fig 6A). The staining was most 
intensified day 12 (Fig 6C), but was diminished in the restricted sites 
where feather buds are being developed on day 15 (Fig 6D). The 
intensities of the staining in the epidermal-dermal junction between 
feather buds were subsequently decreased and were no longer de-
tectable by day 18 (figures not shown) . 
In human fetus, comparable type II collagen staining was ob-
served in the epidermal-dermal junction of the scalp skins at 17 (not 
shown), 21 (arrows in Fig 6E), and 23 (small arrows in Fig 6F) weeks, 
excluding the sites where hair follicles are being formed (large arrow 
in Fig 6F), as was observed in chick embryonic skins (Fig 6D). 
However, type II collagen staining was not detected in the back skin 
at 17 weeks' gestation and scalp skin of the 23-year-old normal adult 
(not shown). 
DISCUSSION 
Transient expression of type II collagen during the very early stages 
(day 2) of chick embryonic development has been reported in the 
ectodermal-mesenchymal interfaces of whole-surface ectoderm [7]. 
Our studies also demonstrate the absence of type II collagen in the 
chick embryonic skins at the stages of day 8 (Fig 1A) and days 5 - 7 
(figures not shown) by ill situ hybridization studies. This indicates 
that the significance of type II collagen expression at the latter stages 
of development is distinct from that at the very early stages. That 
expression of type II collagen in ocular tissue occurred at a very early 
stage (day 2) has been suggested to be involved in the epithelial-me-
senchymal interaction between retinal pigmented epithelium and 
neural crest-derived periocular mesenchyme, because, of the matrix 
components (fibronectin, laminin, types I, II, and IV collagens) 
existing during the interaction, only type II collagen disappeared 
after completion of the interaction [6]. In contrast, type II collagen 
expression at the latter stages of the skin will be related to the 
development of feather, because the collagen first disappeared at the 
feather regions. This result indicates that type II collagen is corre-
lated with the differentiation of epidermal cells. Because the forma-
tion of feather buds is coincident with keratinization [20] , the most 
characteristic property of differentiated epidermal cells, type II col-
lagen appears to be related to the initiation of keratinization at the 
middle stages of developing skin. 
It is noted that type II collagen was also detected in human fetal 
scalp skin during 17 -23 weeks but not in adult scalp skin (not 
shown). This will suggest that type II collagen is also expressed at 
the middle stages of the human fetus, then disappears at a certain 
stage during the subsequent development and maturation. We were 
unable to detect type II collagen in the back skin at 17 weeks, 
possibly because the disappearance of type II collagen in the back 
skin occurs earlier than in the scalp, or expression of type II collagen 
is restricted in the scalp. 
From the results of ill situ hybridization, RNase protection assays, 
and immunohistochemical studies, there was a good correlation 
between the expression of type II collagen gene and gene product in 
chick embryonic skin. These results suggest that the expression of 
type II collagen is explained by the activation of type II collagen 
gene transcription. Type II procollagen has been reported to be 
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expressed in two mRNAs by differential splicing of the primary 
gene transcript that either includes (type II A) or excludes (type II B) 
an exon 2 encoding the major portion of the amino terminal pro-
peptide [21]. Each procollagen mRNA has a distinct tissue distribu-
tion during chondrogenesis, with type II B expressed in chondro-
cytes and type II A expressed in the cells surrounding the cartilage in 
prechondrocytes [22]. It will be of interest to study which form of 
type II collagen mRNA was expressed during skin development, 
although we are not able to tell because the probe used in this study 
was derived from the carboxy terminal propeptide. 
It has been reported that the (X3 (XI) chain has an identical pri-
mary structure to the (Xt (II) chain and differs only in posttransla-
tional modification [23]. Therefore the possibility still remains that 
the RNA probe and antibody for (Xt (II) could be cross-reacted with 
type XI collagen. 
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